John V. Jacobi
Dorothea Dix Professor of Health Law & Policy, Seton Hall Law School

When:
Friday, April 4, 2025 | 8:00 a.m. - 4:30 p.m.
Where:
Seton Hall Law School, One Newark Center (1109 Raymond Blvd.), Newark, NJ 07102
Rodino Law Library
Description:
The Hepatitis C Elimination Symposium will convene healthcare professionals, researchers,
               policymakers, advocates, and stakeholders to discuss epidemiology and public health;
               screening and diagnosis strategies for expanding testing; health equity and access
               including addressing barriers to care, harm reduction approaches, and serving underrepresented
               populations; and policy and advocacy.
Registration:
Continuing Legal Education (CLE) Credits:
CLE credits in NJ, NY (based on the Rule of Reciprocity with NJ), and PA are available
               for attendees.
Agenda:
8:00 - 9:00 am
Networking Breakfast
Welcome Remarks & Introductions
Keynote Address

John V. Jacobi
Dorothea Dix Professor of Health Law & Policy, Seton Hall Law School

Greta Anschuetz
Assistant Commissioner, Division of HIV, STD & TB Services, New Jersey Department of Health
9:35 - 10:15 am
Overview of Hepatitis C

Laura Taylor, PhD, MCHES
Research Scientist / Viral Hepatitis Coordinator, New Jersey Department of Health

Jihad Slim, MD
Chief of Infectious Diseases, Saint Michael’s Medical Center & Assistant Professor of Medicine, New York Medical College

Greta Anschuetz
Assistant Commissioner, Division of HIV, STD & TB Services, New Jersey Department of Health

Charla Cousar
Harm Reduction Coordinator, New Jersey Department of Health, Division of HIV, STD, and TB Services

Moderator: Brian McGovern, LSW
Chief Executive Officer, North Jersey Community Research Initiative (NJCRI)
10:15 - 10:30 am
Break
10:30 am - 12:00 pm
NJCRI Elimination Efforts and Services

Kevin Leyden, RN, BSN
HCV Elimination Program Manager / Research Nurse Coordinator,
North Jersey Community Research Initiative (NJCRI)

Emily Levaggi, CPhT
Program Manager Hepatitis C Elimination Program / 340B / Specialty Medications,
North Jersey Community Research Initiative (NJCRI)

Juan Torres, CMA
Lead Hepatitis CMA, HCV Elimination Program, North Jersey Community Research Initiative (NJCRI)

Sheena Duprey, LPN
Disease Surveillance Nurse, North Jersey Community Research Initiative (NJCRI)

Anthony Raymond
Case Manager, Hepatitis C Elimination Program, North Jersey Community Research Initiative (NJCRI)

Jamel Gray
Mobile Phlebotomist, Hep C Elimination Department, North Jersey Community Research Initiative (NJCRI)

Alex Grant
Managing Director, Community Pride Pharmacy

Moderator: Corey Rosmarin-DeStefano
Director of Research, North Jersey Community Research Initiative (NJCRI)
12:00 - 1:00 pm
Lunch Break
Keynote Address

Susan Julius, MD, DABPM, DABFM, FASAM, CMRO
Regional Medical Director, Avenues Recovery Center
Learn more about Susan Julius, MD, DABPM, DABFM, FASAM, CMRO
1:00 - 2:00 pm
Clinical Best Practices
Harm Reduction
Reinfection & Recovery
Public Health Field Work/Advocacy
Around the Globe & Country
Best Practices & Barriers
Successes & Needs
Public Health Law

Jessica Tkacs, RN, BSN, MS
Harm Reduction Health Nurse, Camden Area Health Education Center (Camden AHEC)

Jessica Lynn Sousa, RN, CARN
Regional Director of Nursing, Pinnacle Treatment Centers

Norma Feliciano, RN, DON
Director of Nursing, Straight and Narrow Detox

Erika Ferradino, BSN, RN, CARN
Director of Nursing, North Jersey Community Research Initiative (NJCRI)

Moderator: Kevin Leyden, RN, BSN
HCV Elimination Program Manager / Research Nurse Coordinator,
North Jersey Community Research Initiative (NJCRI)
2:30 - 2:45 pm
Break
2:45 - 4:00 pm
Advocacy & Funding

Peggy Tighe
Principal, Legislative Group, Powers Pyles Sutter & Verville PC

John V. Jacobi
Dorothea Dix Professor of Health Law & Policy, Seton Hall Law School

Magda Schaler-Haynes
Professor of Health Policy and Management and of Population and Family Health, Mailman School of Public Health, Columbia University

Moderator: Emily Levaggi, CPhT
Program Manager Hepatitis C Elimination Program / 340B / Specialty Medications,
North Jersey Community Research Initiative (NJCRI)
4:00 - 4:30 pm
Wrap Up & Q&A
Closing Remarks

Kevin Leyden, RN, BSN
HCV Elimination Program Manager / Research Nurse Coordinator,
North Jersey Community Research Initiative (NJCRI)